World Health Organization. Schizophrenia: An International Follow-up Study. John Wiley and Sons, 1979.
Jablensky, A, Sartorius, N, Ernberg, G, Anker, M, Korten, A, Cooper, JE, et al. Schizophrenia: manifestations, incidence and course in different cultures. A World Health Organisation ten-country study. Psychol Med Monograph Suppl
1992; 20: 1–97.
Sartorius, N, Jablensky, A, Shapiro, R. Cross-cultural differences in the short-term prognosis of schizophrenic psychoses. Schizophr Bull
1978; 4: 102–13.
Leff, J, Sartorius, N, Jablensky, A, Korten, A, Ernberg, G. The International Pilot Study of Schizophrenia: five-year follow-up findings. Psychol Med
1992; 22: 131–45.
Harrison, G, Hopper, K, Craig, T, Laska, E, Siegel, C, Wanderling, J, et al. Recovery from psychotic illness: a 15- and 25-year international follow-up study. Br J Psychiatry
2001; 178: 506–17.
Hopper, K, Wanderling, J. Revisiting the developed versus developing country distinction in course and outcome in schizophrenia: results from ISoS, the WHO collaborative follow-up project. Schizophr Bull
2000; 26: 835–46.
Kulhara, P, Chakrabarti, S. Culture and schizophrenia and other psychotic disorders. Psychiatr Clin North Am
2001; 24: 449–64.
Cohen, A, Patel, V, Thara, R, Gureje, O. Questioning an axiom: better prognosis for schizophrenia in the developing world?
2008; 34: 229–44.
Patel, V, Cohen, A, Thara, R, Gureje, O. Is the outcome of schizophrenia really better in developing countries?
Rev Bras Psiquiatr
2006; 28: 149–52.
Ciompi, L. Catamnestic long-term study on the course of life and aging of schizophrenics. Schizophr Bull
1980; 6: 606–18.
Harding, CM, Brooks, GW, Ashikaga, T, Strauss, JS, Breier, A. The Vermont longitudinal study of persons with severe mental illness, II: Long-term outcome of subjects who retrospectively met DSM-III criteria for schizophrenia. Am J Psychiatry
1987; 144: 727–35.
Huber, G, Gross, G, Schuttler, R. A long-term follow-up study of schizophrenia: psychiatric course of illness and prognosis
Acta Psychiatr Scand
1975; 52: 49–57.
Ogawa, K, Miya, M, Watarai, A, Nakazawa, M, Yuasa, S, Utena, H. A long-term follow-up study of schizophrenia in Japan – with special reference to the course of social adjustment. Br J Psychiatry
1987; 151: 758–65.
Robinson, DG, Woerner, MG, McMeniman, M, Mendelowitz, A, Bilder, RM. Symptomatic and functional recovery from a first episode of schizophrenia or schizoaffective disorder. Am J Psychiatry
2004; 161: 473–9.
Shepherd, M, Watt, D, Fallon, I, Smeeton, N. The natural history of schizophrenia: a five-year follow-up study of outcome and prediction in a representative sample of schizophrenics. Psychol Med Monogr Suppl
1989; 15: 1–46.
Lambert, M, Schimmelmann, BG, Naber, D, Schacht, A, Karow, A, Wagner, T, et al. Prediction of remission as a combination of symptomatic and functional remission and adequate subjective well-being in 2960 patients with schizophrenia. J Clin Psychiatry
2006; 67: 1690–7.
Wunderink, L, Sytema, S, Nienhuis, FJ, Wiersma, D. Clinical recovery in first-episode psychosis. Schizophr Bull
2009; 35: 362–9.
Boden, R, Sundstrom, J, Lindstrom, E, Lindstrom, L. Association between symptomatic remission and functional outcomes in first-episode schizophrenia. Schizophr Res
2009; 107: 232–7.
Haro, JM, Edgell, ET, Jones, PB, Alonso, J, Gavart, S, Gregor, KJ, et al. The European Schizophrenia Outpatient Health Outcomes (SOHO) Study: rationale, methods and recruitment. Acta Psychiatr Scand
2003; 107: 222–32.
Haro, JM, Edgell, ET, Novick, D, Alonso, J, Kennedy, L, Jones, PB, et al. Effectiveness of antipsychotic treatment for schizophrenia: 6-month results of the Pan-European Schizophrenia Outpatient Health Outcomes (SOHO) Study. Acta Psychiatr Scand
2005; 111: 220–31.
Dossenbach, M, Arango-Davila, C, Silva Ibarra, H, Landa, E, Aguilar, J, Caro, O, et al. Response and relapse in patients with schizophrenia treated with olanzapine, risperidone, quetiapine, or haloperidol: 12-month follow-up of the Intercontinental Schizophrenia Outpatient Health Outcomes (IC-SOHO) study. J Clin Psychiatry
2005; 66: 1021–30.
Haro, JM, Novick, D, Suarez, D, Alonso, J, Lepine, JP, Ratcliffe, M, et al. Remission and relapse in the outpatient care of schizophrenia. Three-year results from the Schizophrenia Outpatient Health Outcomes Study. J Clin Psychopharmacol
2006; 26: 571–8.
Dossenbach, M, Pecenak, J, Szuic, A, Irimia, V, Anders, M, Logozar-Perkovic, D, et al. Long-term antipsychotic monotherapy for schizophrenia: disease burden and comparative outcomes for patients with olanzapine, quetiapine, risperidone, or haloperidol monotherapy in a pan-continental observational study. J Clin Psychiatry
2008; 69: 1901–15.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (4th edn) (DSM-IV). APA, 1994.
World Health Organization. The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines. WHO, 1992.
Haro, JM, Kamath, SA, Ochoa, S, Novick, D, Rele, K, Fargas, A, et al. The clinical global impression–schizophrenia scale: a simple instrument to measure the diversity of symptoms present in schizophrenia. Acta Psychiatr Scand
2003; 107 (suppl 416): 16–23.
Haro, JM, Ochoa, S, Gervin, M, Mavreas, V, Jones, P. Assessment of remission in schizophrenia with the CGI and CGI-SCH scales (Letter). Acta Psychiatr Scand
2007; 115: 163–4.
Andreasen, NC, Carpenter, WT Jr, Kane, JM, Lasser, RA, Marder, SR, Weinberger, DR. Remission in schizophrenia: proposed criteria and rationale for consensus. Am J Psychiatry
2005; 162: 441–9.
Kay, SR, Fiszbein, A, Opler, LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull
1987; 13: 261–76.
Nuechterlein, KH, Dawson, ME. A heuristic vulnerability/stress model of schizophrenic episodes. Schizophr Bull
1984; 10: 300–12.
Grossman, LS, Harrow, M, Rosen, C, Faull, R. Sex differences in outcome and recovery from schizophrenia and other psychotic and nonpsychotic disorders. Psychiatr Serv
2006; 57: 844–50.
Usall, J, Ochoa, S, Araya, S, Marquez, M. Gender differences and outcome in schizophrenia: a 2-year follow-up study in a large community sample. Eur Psychiatry
2003; 18: 282–4.
Marshall, M, Lewis, S, Lockwood, A, Drake, R, Jones, P, Croudace, T. Association between duration of untreated psychosis and outcome in cohorts of first-episode patients. Arch Gen Psychiatry
2005; 62: 975–83.
Farooq, S, Large, N, Nielssen, O, Waheed, W. The relationship between the duration of untreated psychosis and outcome in low- and-middle income countries: a systematic review and meta analysis. Schizophr Res
2009; 109: 15–23.
Volkow, ND. Substance use disorders in schizophrenia – clinical implications of comorbidity. Schizophr Bull
2009; 35: 469–72.
Buhler, B, Hambrecht, M, Loffler, W, an der Heiden, W, Hafner, H. Precipitation and determination of the onset and course of schizophrenia by substance abuse – a retrospective and prospective study of 232 population-based first illness episodes. Schizophr Res
2002; 54: 243–51.
Oosthuizen, P, Emsley, RA, Roberts, MC, Turner, J, Keyter, L, Keyter, N, et al. Depressive symptoms at baseline predict fewer negative symptoms at follow-up in patients with first-episode schizophrenia. Schizophr Res
2002; 58: 247–52.
Conley, RR, Ascher-Svanum, HR, Zhu, B, Faries, DE, Kinon, BJ. The burden of depressive symptoms in the long-term treatment of patients with schizophrenia. Schizophr Res
2007; 90: 186–97.
Warner, R. Recovery from schizophrenia and the recovery model. Curr Opin Psychiatry
2009; 22: 374–80.
Marwaha, S, Johnson, S. Schizophrenia and employment – a review. Soc Psychiatry Psychiatr Epidemiol
2004; 39: 337–49.
Thornicroft, G, Brohan, E, Rose, D, Sartorius, N, Leese, M. Global pattern of experienced and anticipated discrimination against people with schizophrenia: a cross-sectional survey. Lancet
2009; 373: 408–15.
Yanos, PT, Roe, D, Markus, K, Lysaker, PH. Pathways between internalized stigma and outcomes related to recovery in schizophrenia spectrum disorders. Psychiatr Serv
2008; 59: 1437–42.